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of TAG (1). This renders DGAT2 essentially rate-limiting 
for the de novo formation of TAG in the liver (2), and is 
consistent with the observation that the liver of mice lack-
ing a key enzyme of the glycerol-3-P pathway (Gpat 1/) is 
depleted of TAG and is unable to esterify de novo synthe-
sized FA to TAG (3). Although DGAT2 also participates in 
the maintenance of the TAG pool(s) in lipid droplets 
through the lipolysis-reesterification cycling that occurs be-
tween TAG and DG (4), the esterification between pre-
formed FA and partial glycerides is primarily performed by 
DGAT1 in HepG2 cells (1) and in murine liver (5). This is 
consistent with the observations that Dgat 1/ and Dgat 
2/ mice have very different phenotypes, with Dgat 1/ 
animals having a metabolically favorable phenotype (in-
cluding lower plasma and tissue TAG) (6), whereas Dgat 
2/ animals die within several hours after birth and are 
devoid of TAG (lipopenic) (7). This specialization of he-
patic DGAT2 for the utilization of de novo synthesized FAs 
is readily rationalized in view of the role of the liver in inte-
grating glycemia, triglyceridemia, and hepatic TAG content, 
and accommodating large fluxes of glucose metabolism, 
de novo lipogenesis (DNL), and TAG synthesis and secre-
tion (2). However, the wider applicability of this functional 
specialization of DGAT2 to other tissues and conditions 
remains to be determined (8, 9).
Brown adipose tissue (BAT) is another tissue that, like 
the liver, clears large amounts of both glucose and FAs 
(either nonesterified or as products of lipoprotein lipase 
action on triglyceride-rich lipoproteins) from the circulation 
(10). The very high rates of uptake have been suggested to 
Abstract Brown adipose tissue uptake of glucose and fatty 
acids is very high during nonshivering thermogenesis. Ad-
renergic stimulation markedly increases glucose uptake, de 
novo lipogenesis, and FA oxidation simultaneously. The 
mechanism that enables this concerted response has hith-
erto been unknown. Here, we find that in primary brown adi-
pocytes and brown adipocyte-derived cell line (IMBAT-1), 
acute inhibition and longer-term knockdown of DGAT2 links 
the increased de novo synthesis of fatty acids from glucose 
to a pool of TAG that is simultaneously hydrolyzed, provid-
ing FA for mitochondrial oxidation. DGAT1 does not con-
tribute to this pathway, but uses exogenous FA and glycerol 
to synthesize a functionally distinct pool of TAG to which 
DGAT2 also contributes. The DGAT2-dependent channelling 
of 14C from glucose into TAG and CO2 was reproduced in 
3-agonist-stimulated primary brown adipocytes. Knockdown 
of DGAT2 in IMBAT-1 affected the mRNA levels of UCP1 
and genes important in FA activation and esterification.  
Therefore, in 3-agonist activated brown adipocytes, DGAT2 
specifically enables channelling of de novo synthesized FA 
into a rapidly mobilized pool of TAG, which is simultane-
ously hydrolyzed to provide substrates for mitochondrial 
fatty acid oxidation.—Irshad, Z., F. Dimitri, M. Christian. 
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The diacylglycerol acytransferases, DGAT1 and DGAT2, 
catalyze the last, dedicated step of triacylglycerol (TAG) 
synthesis. Although they catalyze the same reaction (with 
minor differences in substrate preferences) and are coex-
pressed in all the cell types in which they occur, they are func-
tionally nonredundant. In particular, in the liver, DGAT2 is 
specialized for the formation of TAG from de novo synthe-
sized fatty acids and newly formed diglycerides (DGs) 
thus acting upstream of DGAT1 in the de novo synthesis 
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Body of the University of Warwick. Black c57b16 mice were used. 
Primary brown adipocytes were prepared from the stromal frac-
tion resulting from the collagenase digestion of inter-scapular 
BAT obtained from 4-week-old mice. The stromal fraction was sus-
pended in DMEM10, filtered through a 40 m strainer, and cells 
plated in T25 flasks. The cells were allowed to expand until 80–
90% confluent with regular replacement of media. After trypsin-
ization and resuspension in DMEM10, 5 × 104cells/well of a 
12-well plate were then plated and allowed to reach 100% con-
fluence. Differentiation was induced by addition of medium 
containing insulin (1 g/ml), IBMX (250 uM), triiodothyronine, 
T3 (1 nM), indomethacin (30M), rosiglitazone (2 M), and 
dexamethasone (0.5 M). After 96 h, during which the medium 
was replenished once, the cells were switched to maintenance me-
dium (DMEM10) supplemented with insulin, T3, and rosigli-
tazone only. After a further 48 h, the cells were switched to a 
medium which contained the same concentrations of insulin and 
T3, but from which rosiglitazone was omitted. After a further 48 h, 
the medium was changed to DMEM10 only, and the cells were 
used for experimental treatments.
Generation, differentiation and culture of IMBAT-1 cells
The immortalized brown adipocyte cell line (IMBAT-1) was 
generated as described previously (31). Briefly, preadipocytes iso-
lated from murine interscapular BAT were immortalized by retro-
viral-mediated expression of temperature-sensitive SV40 large 
T-antigen H-2kb-tsA58. Cells were cultured in DMEM-F12 (20 mM 
D glucose) supplemented with 10% FBS, 1% L-glutamine, 1% 
penicillin/streptomycin, Amphotericin B, and 50 g/ml of G418 
at 33°C in 5% CO2 and 95% air-water saturated atmosphere. Un-
less specified otherwise, cells were passaged and harvested after 
treatment with 0.25% trypsin and 0.02% EDTA. For differentia-
tion to mature adipocytes, preadipocytes were plated onto gelatin-
coated plates and cultured until confluent. Induction medium 
containing 7.5 mM glucose, 1 g/ml insulin, 250 nM dexametha-
sone, 0.5 mM IBMX, 1 nM triidothyronine (T3), and 125 M 
Indomethacin was added for 48 h at 37°C. Cells were then main-
tained in 7.5 mM glucose medium containing 1 nM T3 and 1 g 
insulin/ml for 5 days at 37°C. Unless otherwise stated, all experi-
ments were performed on day 7 of differentiation or after a fur-
ther 72 h treatment with siRNA. The experimental incubation 
medium was DMEM-F12 containing 7.5 mM D-glucose, 10% FBS, 
1% L-glutamine, 1% penicillin/streptomycin, 1 mM L-carnitine, 
0.75 mM oleate with 0.25% BSA, and 0.75 mM glycerol.
SiRNA-mediated knockdown of DGAT1 or DGAT2
Transfections were carried out on day 7 of differentiation using 
Smartpool siRNA, designed by the manufacturers for DGAT1 
and DGAT2, and transfection reagent lipofectamine RNAiMax, 
following the manufacturer’s instructions. Differentiated adipo-
cytes were dissociated with trypsin/EDTA followed by addition of 
DMEM/F12 with 10% FBS. Mixtures of transfection reagents, 
OptiMEM medium, and 10 M siRNA-DGAT1 or 10 M siRNA-
DGAT2 or 10 M siRNA-control were incubated at room tempera-
ture for 25 min. They were then added to the dissociated cells 
along with antibiotic-free DMEM-F12 (7.5 mM glucose). Control 
cells were treated with scrambled siRNA. Media were changed 
after 24 h and cells were cultured for further 48 h at 37°C in 
maintenance medium. Preliminary experiments established that 
optimal knockdowns were achieved after 72 h of siRNA treatment.
Measurement of the incorporation of 14C-glucose label 
into CO2 and cellular TAG
IMBAT-1 or primary brown adipocytes cells plated in gelatin-
coated 6-well plates containing 7.5 mM glucose medium were 
incubated for 2 h in the presence or absence of the 3-adrenergic 
play a role in the regulation of glycemia and triglyceride-
mia, respectively (11–13). During cold exposure, BAT has 
the highest rate of glucose uptake and lipogenesis when 
compared with white adipose tissue and the liver (14). BAT 
glucose metabolism is independent of insulin but, during 
-adrenergic stimulation, is stimulated by an increase in 
GLUT1 expression (via cAMP) and translocation to the 
plasma membrane, mediated through mTORC2 (15, 16). 
Although glucose makes a relatively minor direct contribu-
tion (<20%) toward thermogenesis (through glycolysis and 
oxidation of pyruvate) (17, 18), the contribution through 
oxidation of FA synthesized de novo from glucose and 
other lipogenic substrates [e.g., lactate (19)] could be con-
siderably larger (13). Indeed, when nonshivering thermo-
genesis is maximally stimulated, BAT can account for 33% 
of whole-body lipogenesis, and newly synthesized FAs make 
a significant contribution toward the thermogenic capacity 
of BAT in adult rodents (14). The very substantial lipogenic 
capacity of BAT (20) and its activation in vivo upon cold-
exposure of animals (21, 22) are accompanied by increased 
nuclear expression of SREBP1 and elevated gene expres-
sion of lipogenic and FA-elongation enzymes when mice 
are maintained at subthermoneutral temperatures (23).
Therefore, in view of the very high lipogenic potential of 
BAT (10, 24, 25), the contribution of de novo synthesized 
FA toward BAT thermogenesis may be substantial (13, 26). 
FAs, whether provided exogenously or synthesized de novo 
from glucose, activate UCP1 (by overriding the inhibitory 
action of purine nucleotides on the protein) and provide 
the ultimate substrate for uncoupled respiration in brown 
adipocytes (27). Glucose is also required to form glycerol-
3-P for the (re)synthesis of TAG from FA. Therefore, like 
the liver, BAT has to integrate large fluxes of glucose and 
fatty acid metabolism, and may be a tissue in which the dis-
tinctive functions of DGAT1 and DGAT2 may be important 
in directing different FA pools toward specific pathways 
during adrenergic stimulation, when glucose uptake, de 
novo lipogenesis (DNL), and TAG lipolysis are all coordi-
nately activated (21, 22, 28). Expression profiling of mouse 
tissues indicates that DGAT2 is expressed in BAT judging 
by the high level of its mRNA expressed in the tissue (29) 
and that its expression is increased (more than that of 
DGAT1) in BAT of cold-acclimated rodents (30). There-
fore, in the present study, we investigated the roles of 
DGAT1 and DGAT2 in the metabolism of glucose and de 
novo synthesized FAs, compared with that of exogenous 
fatty acids in a brown adipocyte cell line (IMBAT-1) and in 
mouse primary brown adipocytes. We identified a specific 
role for DGAT2 in linking glucose uptake and DNL to the 
formation of TAG that acts directly as a source of FAs for 
oxidation, independent of the uptake and metabolism of 
extracellular FAs.
MATERIALS AND METHODS
Preparation and culture of primary brown adipocytes
All animal maintenance and usage was made in accordance 
with the requirements of the Animal Welfare and Ethical Review 
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for 5 min before chilling on ice. Subsequently, 8 µl of mixture 
containing RNase inhibitor (10 U/µl), dNTPs (10 mM), Bioscript 
reverse transcriptase and RNase free water were added to each 
sample. Samples were heated at 40°C for 60 min and the reaction 
was stopped by heating to 70°C for 10 min. The cDNA formed was 
mixed with 180 µl of nuclease-free water and stored at 20°C. 
Samples were thawed only once before quantification. RT-PCR 
was performed using SYBR green dye and expression for all the 
samples (n  3) was calculated by using the DCt method, incorpo-
rating the efficiencies of each primer. The variances of input 
cDNA were normalized against the levels of three housekeeping 
genes: L19, B-actin, and 36B4. Melting curve analysis confirmed 
amplification specificity. The primers used are detailed in supple-
mental Table S1.
Statistical analyses
Differences between means for independent groups of data 
were analyzed by ANOVA followed by the post hoc Tukey test.
Materials
DMEM10, DMEMF12, etomoxir sodium salt, CL, L-carnitine, 
benzethonium hydroxide, light petroleum (bp: 40-60°C), glyceryl 
tripalmitate, sodium oleate, insulin, IBMX, Indomethacin, and 
3,3′5-triiodo-L-thyamine were purchased from Sigma-Aldrich. 
TLC-pre-coated plates, 10 ml conical flasks with center wells, lipo-
fectamine, and RNAiMax were purchased from Fischer Scientific. 
Rosiglitazone was from Cayman Chemical. Radiolabeled [U-14C]
glucose (specific activity 250–360 mCi/mmol), [1-14C] Oleic 
acid (specific activity: 40–60 mCi/mmol) and [2-3H] glycerol 
(specific activity 0.5–1.0 Ci/mmol) was purchased from Perkin 
Elmer LAS (UK). ON-TARGETplus Mouse Dgat1 smartpool 
siRNA, ON-TARGETplus Mouse Dgat2 smartpool siRNA, and 
ON-TARGETplus nontargeting siRNA were purchased from 
GE Healthcare UK. Of the three inhibitors of DGAT activity 
used, DGAT1iB (cis-4-{3-fluoro-4-[({5-[(4-fluorophenyl)amino]1,3,4-
oxadiazol-2-yl}carbonyl)-amino]phenoxy} cyclohexane carboxylic 
acid) and DGAT2-iC (N-(4,5-dihydronapththol[1.2-d]thiazol-
2-yl)-2-(3,4-dimethoxyphenyl)acetamide) were obtained from 
Astra Zeneca and have been used previously as DGAT1 and DGT2 
inhibitors, respectively (33). A third inhibitor, DGAT2-iJ 
(3-bromo-4-[2-fluoro-4-({4-oxo-2-[(2-pyridin-2-ylethyl)amino]1,3-
thiazol-5(4H)-ylidene}methyl)phenoxy] benzonitrile) was ob-
tained from Janssen Research and Development UK, and has 
been used previously as a specific DGAT2 inhibitor (5). All 
primers were purchased from Sigma-Aldrich.
RESULTS
Experiments using the brown adipocyte-derived cell line 
IMBAT-1
In view of the large amount of preliminary work that was 
needed to establish the conditions under which the meta-
bolic fluxes of interest could be measured, and the concen-
trations of inhibitors required, we used a well-established 
brown adipocyte-derived cell line, IMBAT-1. This cell line 
has been well characterized, and has been shown to ex-
press all the proteins that are characteristic of brown adipo-
cytes, especially UCP1 (35). Their use also allowed us to 
verify the effects observed with specific DGAT1 and DGAT2 
inhibitors through the efficient knockdown of the two pro-
teins in these cells using siRNA. The main findings were 
validated using primary brown adipocytes (see below).
agonist CL (10 M) before the addition of label to start the mea-
surements. Preliminary experiments established the incorpora-
tion of [U-14C]glucose into labeled products was linear for 2 h and 
this period was used routinely when [U-14C]glucose incorporation 
was studied. Where indicated, oleate or palmitate (0.75 mM plus 
0.25% albumin) and glycerol (0.75 mM) were added to the incu-
bations. When incorporation of label from 1-[14C]oleate, U-[14C]
palmitate, or 2-[3H]glycerol was measured, the labeling period 
was 1 h to ensure linearity of incorporation into TAG. In one se-
ries of experiments, labeling with exogenous 1-[14C]oleate was 
extended to 8 h to monitor the release of 14CO2. When effects of 
DGAT1 or DGAT2 inhibition were studied, the appropriate in-
hibitors were added 30 min before the start of the incubations 
with the label. Where indicated, etomoxir (80 µM) was added 30 
min before the start of the experimental period by addition U-14C-
glucose label. Lipolysis was inhibited by addition of tetrahydrolip-
statin (THL, 200 M) or Atglistatin (10 M) at the same time as 
the addition of CL; i.e., 2 h before the addition of U-14C-glucose 
label.
Measurement of 14CO2 labeling
Formation of 14CO2 after incubation of cells with labeled sub-
strates for the required period of time was measured by transfer-
ring 1 ml of the incubation medium to a 20 ml glass conical flask 
containing a 0.5 ml Fisher center well holding filter paper to 
which 400 l of benzethonium hydroxide had been added (32). 
The flask was stoppered and 1.0 ml of 1 M H2SO4 was injected 
through the rubber stopper. The flasks were shaken for 60 min at 
37°C to allow the liberated 14CO2 to be absorbed by the benzetho-
nium hydroxide, after which the radioactivity associated with the 
contents of the center well was quantified using a liquid scintilla-
tion counter.
Measurement of incorporation of label into TAG
At the end of the incubation period, the cells were washed 
with cold PBS and total lipids were extracted from them using a 
chloroform/methanol mixture (2:1 v/v) (33). The chloroform 
layer was aspirated into a glass tube and dried under a stream of 
N2 gas. The dried material was resolubilized in chloroform (500 
l) and the entire volume was applied onto a TLC plate coated 
with Silica Gel 60 for separation of the radioactive triglyceride 
product, using hexane/diethyl ether/formic acid (70:30:1, v/v/v) 
as the mobile phase. A TAG-standard (tripalmitin) was used to 
identify the position of the TAG band visualized using iodine 
vapor. The radioactivity associated with each band was quantified 
after scraping into scintillation vials, addition of scintillant (Ultima 
GoldTM, Perkin Elmer) and measuring the associated radioactivity 
using a scintillation counter.
Saponification of the total lipids was performed as described in 
(34) with minor modifications. The cellular total lipid extract was 
dried and dissolved in 0.75ml of 30% KOH and heated at 70°C for 
10 min. An equal volume of 95% ethanol was then added and the 
mixture was heated at 70°C for 2 h. After cooling, the aqueous 
fraction was acidified with 3M HCl and extracted three times with 
light petroleum. The organic fraction was evaporated, redissolved 
in 1 ml of light petroleum, transferred to a scintillation vial, and 
quantified as the TAG-acyl fraction. The remaining aqueous frac-
tion contained the TAG-glyceryl fraction; a 0.5 ml aliquot of this 
sample was taken and measured for radioactivity using scintilla-
tion counter.
Real time PCR quantitation of mRNA expression
Total RNA was extracted from IMBAT-1 cells using TRIzol re-
agent. cDNA was prepared using reverse transcription. Briefly, 
RNA (1 ug) was mixed with oligodT (1 µl) in a final volume of 
12 µl by adding RNase free water. Samples were heated at 70°C 
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rates of labeling from U-14C-glucose into TAG and CO2 in 
IMBAT-1 cells, and ascertained that they were linear dur-
ing the 2 h period of the incubations (not shown). Stimula-
tion of IMBAT-1 cells with the 3-agonist CL316324 (CL) 
for 2 h before the start of incubations (by addition of U-14C-
glucose label) resulted in a significant increase in the in-
corporation of 14C-label from glucose into CO2 (Fig. 3A). 
The rates of CL-stimulated glucose incorporation were 
22.8 ± 1.3 and 50.6 ± 1.0 pmol/h/106cells for TAG-acyl and 
TAG-glyceryl moieties, respectively. The incorporation 
into CO2 was 10.6 ± 1.4 pmol/h/10
6cells, although this flux 
is not directly comparable to the previous two, as i) 14CO2 is 
generated both during lipogenesis and FA oxidation, and 
ii) 14CO2 derived from the oxidation of de novo synthe-
sized FAs will have been diluted by unlabeled acyl moieties 
within the preexisting TAG pool. From the observation 
that 106 cells yield 10 mg wet weight of cellular mate-
rial, it is calculated that these rates are of the same order 
of magnitude as the values reported for glucose uptake 
(7.2 µm/h/g) and de novo lipogenesis rates (4.8 µm/h/g) 
in cold-acclimated rats in vivo (14, 30).
Etomoxir [an inhibitor of CPT1 that controls FA entry 
into mitochondria (36)] inhibited CO2 labeling margin-
ally under basal conditions (Fig. 3) suggesting that, as ex-
pected, in the absence of CL-stimulated TAG lipolysis, CO2 
DGAT2 mRNA expression is preferentially induced during 
differentiation. We investigated the expression of DGATs 
across a panel of murine tissues. DGAT2 mRNA was most 
highly expressed in BAT, and present at much lower levels 
in white adipose tissue, liver, intestine, and mammary 
gland (Fig. 1). DGAT1 mRNA was most highly expressed in 
the intestine, followed by BAT, white adipose tissue, and 
mammary gland. We then studied the profile of mRNA ex-
pression for both DGATs, compared with the differentia-
tion marker aP2 during brown adipocyte differentiation. 
All three mRNAs were induced at day 2 of differentiation, 
but whereas DGAT1 mRNA was induced moderately (7-fold) 
during the first days of differentiation, leveling off thereaf-
ter and declining on day 6, DGAT2 mRNA was induced 
50-fold and continued to be induced throughout the pe-
riod of differentiation (Fig. 2). This time course of the ex-
pression of the two genes is the opposite to that previously 
described during the differentiation of white adipocytes, in 
which an initial peak in DGAT2 expression (during initial 
differentiation with glucose as the main substrate) is over-
taken by a sustained expression of DGAT1 mRNA during 
the latter stages of differentiation (35).
3-adrenergic stimulation increases incorporation of de novo 
synthesized FA into TAG and CO2. We next measured the 
Fig. 1. DGAT1 and DGAT2 mRNA expression in 
mouse tissues. The levels of mRNA expression of (A) 
DGAT1 and (B) DGAT2 were measured in the mouse 
tissues indicated. Values are means (± SEM) for three 
separate determinations. See Methods section for de-
tails of the normalization of the data. WAT, white adi-
pose tissue; SKM, skeletal muscle.
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generated by TAG lipolysis activates one or more steps in 
the pathway leading from glucose to TAG synthesis, and 
occurs independently of the interruption of the provision 
of FA for oxidation as a result of the inhibition of TAG hy-
drolysis. This positive feedback on TAG synthesis supports 
previous observations that TAG lipolysis generates signal-
ing molecules that affect lipogenic fluxes (37–39).
Oxidation of de novo synthesized FAs is DGAT2-dependent.  
InhIbItor studIes. In view of the preferential activation of 
the esterification of de novo synthesized FA into TAG la-
beled from glucose, we studied the possibility that DGAT1 
and DGAT2 may have different roles in the esterification of 
newly synthesized FA into TAG after 3-stimulation of 
IMBAT-1 cells. We used three compounds that have previ-
ously been well characterized as specific inhibitors of the 
two DGATs. Compound DGAT1-iB was previously used 
(1, 33, 40, 41) as a highly specific inhibitor of DGAT1, 
Compound DGAT2-iC (see Methods) was used in (1) as a 
selective inhibitor of DGAT2 at lower concentrations, and 
compound DGAT2-iJ was developed and used as a highly 
specific inhibitor of DGAT2 [(5); see Methods]. As these 
compounds have been developed as inhibitors of human 
enzymes, we performed dose-response studies to ascertain 
that they were effective inhibitors of TAG synthesis in 
IMBAT-1 cells at concentrations that were not deleterious 
to cell viability. The concentrations required for each com-
pound to inhibit incorporation of U-14C-glucose into the 
glyceryl or acyl moieties of TAG (see supplemental Figure 
S1) were similar to those found to be effective in HepG2 
cells and on the recombinant human enzymes (1, 5, 33). 
In the same experiments, we quantified cell viability, as 
judged by MTT mitochondrial viability assays, at the end 
of the 2 h incubations. Thereafter, the effects of DGAT1 or 
DGAT2 inhibition were investigated in detail, using single 
labeling from glucose was due mostly to that generated in 
the course of lipogenesis. The increase in CO2 labeling in-
duced by CL was totally prevented by etomoxir (Fig. 3A). 
As a result, it could be calculated that CL increased the rate 
of 14CO2 labeling due to CPT 1-dependent oxidation of de 
novo synthesized FAs by 4-fold (Fig. 3A).
Stimulation of the cells with CL also activated incorpora-
tion of label from U-14C-glucose into both parts of the TAG 
molecule (glyceryl and acyl, Fig. 3B and C, respectively) 
although differentially. Stimulation of U-14C-glucose incor-
poration into the acyl moieties of the TAG molecule was 
consistently significantly higher (200%) than that into the 
glyceryl moiety of TAG (50%), indicating that, whereas in-
creased glucose uptake by the cells by CL may have been a 
common contributor toward the increased labeling of TAG 
from glucose (25), de novo lipogenesis was stimulated in-
dependently of, and to a higher extent than, the pathway 
leading from glucose to triose phosphates (the last com-
mon intermediates of glycerol-3-P and FA formation). Eto-
moxir did not affect incorporation of glucose into TAG-acyl 
or TAG-glyceryl moieties, confirming that its action is spe-
cific to the inhibition of FA oxidation.
CL-stimulation of glucose incorporation into TAG-FA and their 
oxidation is ATGL-dependent. To test the possible role of 
TAG synthesis and hydrolysis in the provision of glucose-
derived FA for oxidation, we tested the effects of inhibition 
of TAG hydrolysis, using Atglistatin (a specific inhibitor of 
adipose triglyceride lipase, ATGL) and the nonspecific li-
pase inhibitor THL. Both inhibitors prevented all the ef-
fects of CL treatment on CO2 and TAG labeling from 
U-14C-glucose without affecting basal rates (Fig. 4). CL-
stimulation of the incorporation of glucose into both acyl 
and glyceryl moieties of TAG was totally prevented by ATGL 
inhibition by Atglistatin. This indicated that a metabolite 
Fig. 2. Expression of DGAT1, DGAT2 and aP2 dur-
ing differentiation of IMBAT-1 cells. IMBAT-1 cells 
were differentiated for 6 days (see Methods section). 
The fold-activation of DGAT1, DGAT2, and aP2 mRNA 
expression relative to that at day 0, during subsequent 
differentiation. The variances of input cDNA were 
normalized against the levels of three housekeeping 
genes: L19, B-actin, and 36B4. Values are means 
(± SEM) for three separate determinations for sepa-
rate cell preparations. Note different scale of y axis 
for DGAT2. Where error bars are not shown, they lie 
within the symbols.
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incorporation of 14C-glucose into CO2 and TAG-acyl groups 
(see Fig. 5A, B). By contrast, inhibition of DGAT1 (with 
DGAT1-iB) did not affect either incorporation of label 
into 14CO2 (Fig. 5A) or into TAG-acyl groups (Fig. 5B). 
These observations suggest that DGAT2 activity is special-
ized for the esterification of de novo synthesized FAs into 
TAG and subsequent mitochondrial oxidation of FA prod-
ucts of TAG lipolysis. The validity of this conclusion is 
strengthened by the fact that the two inhibitors of DGAT2 
used are structurally unrelated. Both DGAT1 and DGAT2 
inhibition decreased significantly the glucose incorpora-
tion into the glyceride part of TAG (Fig. 5C), indicating 
that glycerol-3-P newly synthesized from glucose is incor-
porated into DG pools that are used by either DGAT1 or 
DGAT2 as substrates.
Importantly, the above observations were not altered 
qualitatively when experiments were conducted in the 
presence of added exogenous glycerol (0.75 mM) and ole-
ate (0.75 mM in the presence of 0.25% albumin) to the 
medium (Fig. 5D–F); only DGAT2 inhibition resulted in 
the loss of labeling from U-14C-glucose into TAG-acyl moi-
eties and CO2 (Fig. 5D, E). Therefore, addition of exoge-
nous oleate (or palmitate, not shown) did not affect the 
ability of DGAT2 inhibition specifically to affect the incor-
poration of de novo synthesized FA into TAG (compare 
concentrations of each compound (see figure legends) that 
gave significant (but less than maximal) inhibition of the pa-
rameters studied but with the retention of full cell viability.
Both the DGAT2 inhibitors tested (DGAT2-iC and 
DGAT2-iJ) resulted in a strong inhibition of the CL-stimulated 
Fig. 3. Etomoxir selectively prevents the increase in glucose-
derived CO2 formation after 3-adrenergic stimulation of IMBAT-1 
cells but not the increased incorporation into the glyceryl and acyl 
moieties of TAG. Cells were incubated with CL for 2 h, followed by 
a further incubation period of 2 h, at the start of which U-14C-
glucose label was added (at zero time) as described in the Methods 
section. Incorporation of label was measured into (A) CO2 and (B) 
glyceryl- and (C) acyl-moieties of TAG. Etomoxir was added 30 min 
before the addition of label. Data are means (± SEM) for three sepa-
rate experiments and are expressed with respect to paired controls, 
which are set at 100% for each experiment. Values that were signifi-
cantly statistically different (P  0.05) are indicated by * (vs. con-
trol) or # (CL+etomoxir vs. CL). See Methods section for details of 
statistical analyses.
Fig. 4. ATGL inhibition prevents 3-induced stimulation of 
U-14C-glucose incorporation into TAG and CO2. Cells were incu-
bated with CL for 2 h before addition of U-14C-glucose, and incorpo-
ration of label into (A) CO2 and (B) TAG was measured during a 
further 2 h incubation (see Methods section). When Atglistatin 
(Astat) or THL were present, they were added at the same time as 
CL. Data are means (± SEM) for three separate experiments and 
are expressed with respect to control values that were set at 100% 
for each experiment. Values that were statistically significantly dif-
ferent (P < 0.05) are indicated by * (CL vs. control) and # (CL+THL 
or CL+ Atglistatin vs. CL).
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relative importance of the two enzymes in this process 
(compare Fig. 5C and F).
dGAt1- And dGAt2-knockdown studIes. To exclude the 
possibility that nonspecific effects of enzyme inhibitors 
were compromising the validity of our observations, we 
investigated the longer-term effects of the knockdown of 
the expression of either protein using individually targeted 
Fig. 5B and 5E) or the formation of CO2 after CL treat-
ment. These observations indicate that de novo synthesized 
FA are compartmentalized rapidly into a pool of TAG 
which is not accessible to exogenously added FA. Addition 
of exogenous glycerol and oleate appeared to increase 
the effect of either DAGT1 or DGAT2 inhibition on glu-
cose incorporation into TAG-glyceryl, but did not affect the 
Fig. 5. Effect of DGAT1 and DGAT2 inhibition on the incorporation of U-14C glucose into CO2 and TAG after 3-agonist stimulation of 
IMBAT-1 cells. Cells were incubated with CL for 2 h before the start of incubations by the addition of U-14C-glucose label. Inhibitors were 
added individually 30 min before the addition of label (see Methods section). Experiments were performed in the absence (A–C) or pres-
ence (D–F) of oleate (0.75 mM with 0.25% BSA) and glycerol (0.75 mM). Incorporation of label from U-14C-glucose was measured for a 2 h 
period into CO2 (A, D), TAG-acyl moieties (B, E), and TAG-glyceryl moieties (C, F). The concentrations of inhibitors used were: DGAT1-iB, 
0.75 µM; DGAT2-iC, 50 µM, and DGAT2-iJ, 50 µM. Values are means (± SEM) for three separate experiments and are expressed with respect 
to values for controls (set at 100%) to which no CL or inhibitors were added. Values that were statistical significantly different (P < 0.05) are 
indicated by * (CL vs. control) and # (CL + inhibitors vs. CL only).
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and quantitatively to those obtained using the respective 
DGAT1 and DGAT2 inhibitors (Fig. 5). Knockdown of 
DGAT2 also had a large inhibitory effect on the incorpora-
tion of glucose into total TAG (Fig. 7B). Saponification of 
the lipid fraction confirmed the preferential stimulus by 
CL of glucose incorporation into the acyl moieties of TAG, 
and showed that DGAT2 knockdown prevented the CL ef-
fects on the incorporation of label from U-14C-glucose into 
both TAG-acyl and TAG-glyceryl moieties under both basal 
and CL-stimulated conditions (Fig. 7E, F). Therefore, ef-
fects of longer-term DGAT2 downregulation with siRNA 
treatment on the formation of TAG-acyl moieties and their 
subsequent use for 14CO2 were identical to those observed 
after short-term inhibition (Fig. 5). By contrast, there was 
no effect on glucose incorporation onto TAG-acyl when 
DGAT1 was knocked down (Fig. 7D) and much smaller ef-
fects than those achieved by DGAT2 knockdown on incor-
poration of glucose into TAG-glyceryl (Fig. 7C). These 
observations confirm that DGAT2 is specialized for the 
channelling of de novo synthesized fatty acids toward oxi-
dation (to CO2) initially through their incorporation into a 
distinct pool of TAG, followed by lipolysis (Fig. 7C, E).
DGAT2 knockdown attenuates the CL-mediated induction of 
UCP1 mRNA expression. In view of the observed close as-
sociation between DGAT2 downregulation and metabo-
lism of de novo synthesized FAs, we investigated whether 
long-term downregulation of DGAT2 or DGAT1 is ac-
companied by changes of lipogenic gene expression. We 
measured the mRNA expression (before and after CL 
treatment) of UCP1 and of several genes that are involved 
in the pathways leading from glucose to TAG synthesis and 
CO2 formation (Fig. 8). Incubation of the cells with CL for 
2 h increased the expression of UCP1 mRNA 5-fold in 
IMBAT-1 cells [as observed previously in BAT in vivo (42)]; 
DGAT2 knockdown resulted in the halving of this increase 
whereas DGAT1 knockdown had no effect (Fig. 8). GPAT4 
mRNA expression after CL treatment was decreased spe-
cifically by DGAT2 knockdown. None of the other genes 
tested (including Elvol3, not shown) showed significant 
differences in mRNA expression levels after CL-stimulation 
or knockdown of either DGAT compared with control 
(scrambled) siRNA-treated cells.
Therefore, knockdown of DGAT2 moderately but spe-
cifically affected the expression of genes that are central to 
elongation of de novo synthesized FA, FA esterification 
(GPAT4), and uncoupling of mitochondrial FA oxidation 
(UCP1) (3, 43, 44) indicating that it may play a central role 
in the maintenance of BAT function.
Direct oxidation of exogenously added oleate is very low. We 
next compared the roles of DGAT1 and DGAT2 in deter-
mining the metabolism of exogenously added, preformed 
fatty acids. We performed a series of experiments in which 
the normal concentration of unlabeled glucose was ac-
companied by glycerol (0.75 mM) and oleate (0.75 mM in 
the presence of 0.25% albumin). We performed parallel 
experiments in which we labeled either the glycerol (2-3H-
glycerol) or oleate (1-14C-oleate). We also used U-14C-palmitate 
siRNA treatment of IMBAT-1 cells. The effects of 72 h 
siRNA treatment on mRNA expression of the DGAT1 
and DGAT2 are shown in Fig. 6. A scrambled sequence 
was used in control cells. Note that reliable quantification 
of protein expression was not possible using a range of 
commercially available antibodies (not shown). Similarly, 
DGAT activities could not be reliably quantified by avail-
able DGAT assays using the amounts of material available. 
However, the fact that both inhibition and knockdown 
studies resulted in identical observations (see below) sug-
gests that the large decreases in mRNA were accompanied 
by similar losses in enzyme activities and protein expression.
The data in Fig. 7A show that knockdown of DGAT2 had 
the same major inhibitory effect on the incorporation of 
label from U-14C-glucose into CO2 both under basal and 
CL-stimulated conditions as shown by the inhibitors, con-
firming that de novo synthesized FA need to be incorporated 
into TAG by DGAT2 before they can undergo mitochondrial 
oxidation. Knockdown of DGAT1 had no effect at all 
(Fig. 7A). Therefore, these data are identical qualitatively 
Fig. 6. Effects of siRNA-mediated DGAT1- or DGAT2-knockdown 
on the respective levels of mRNA expression of the two enzymes. 
Differentiated cells were treated for 72 h with either control (scram-
bled, SC) siRNA, or siRNA targeted toward DGAT1 (SiD1) or 
DGAT2 (SiD2) and the level of (A) DGAT1 and (B) DGAT2 mRNA 
expression was measured. Values (n = 3) are means (± SEM) for a 
representative experiment. Values that were statistically significantly 
different (P < 0.05) from SC are indicated by an asterisk.
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of TAG from either exogenous glycerol or oleate were not 
stimulated by CL, showing that the effects of the 3-agonist 
were specific to the stimulation of glucose metabolism 
and FA derived from it. Although exogenous 1-14C-oleate 
was very rapidly incorporated into TAG (75 ± 9 nmol 
to verify that the effects observed with oleate could be repli-
cated using a saturated FA; the results with palmitate (not 
shown) were identical to those obtained with oleate.
Contrary to the incorporation of de novo synthesized FA 
and glycerol-3-P derived from U-14C-glucose, the labeling 
Fig. 7. Effects of siRNA-mediated DGAT1- or DGAT2-knockdown on the rates of incorporation of U-14C-glucose into CO2 and TAG in the 
presence or absence of 3-adrenergic stimulation of IMBAT-1 cells. Differentiated cells were treated for 72 h with either control (scrambled, 
SC) siRNA or siRNA (SiD) targeted toward DGAT1 (SiD1) or DGAT2 (SiD2) (see Methods section). Cells were incubated +/ CL for 2 h 
followed by the measurement of the incorporation of label from U-14C-glucose into (A) CO2, (B) total TAG, and (C, E) TAG-glyceryl and 
(D, F) TAG-acyl moieties of TAG. Data are means (± SEM) for three separate experiments and are expressed with respect to Control values 
(which are set at 100%) for each experiment. Values that are statistically significantly different (P < 0.05) are indicated by * (SC+CL or SiD 
vs. SC) and # (SiD+CL vs. SC+CL).
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exogenous oleate is esterified is distinct from that into which 
glucose-derived de novo synthesized FAs are esterified by 
DGAT2, since the latter do give rise to 14CO2 linearly over a 
2 h incubation period. This is consistent with the observa-
tion in the “Oxidation of de novo synthesised FA is DGAT2-
dependent” section above, that addition of exogenous 
oleate did not alter the pattern of fluxes of U-[14C]glucose 
into TAG-acyl or TAG-glyceryl moieties. The simplest ex-
planation for these combined observations is that exogenous 
(preformed) oleate is incorporated into a separate, large 
pool of TAG in which the specific activity of 1-14C-oleate is 
highly diluted, resulting in negligible labeling of the CO2 
produced from the oxidation of its constituent FA after 
oleate/h/106 cells), no significant 14C-label above back-
ground was recovered in oxidation products (either CO2 
or acid-soluble metabolites (ASMs). Thus, although incu-
bation with 1-14C-oleate (and U-14C-palmitate) achieved the 
same degree of overall cellular TAG labeling as that 
achieved by U-14C-glucose, only minimal 14C-label was re-
covered in CO2 or ASMs after exposure to 1-
14C-oleate even 
when incubations were extended to 8 h after addition of 
label to eliminate the possibility of a time-lag (not shown). 
There are two conclusions from these observations. First, 
that exogenous FAs are not oxidized directly to CO2 to 
any significant extent, although they are rapidly incorpo-
rated into TAG. Second, that the pool of TAG into which 
Fig. 8. Effect of siRNA-mediated knockdown of 
DGAT1 and DGAT2 on the expression of genes involved 
in pathways leading from glucose to TAG-synthesis 
and CO2 formation. Differentiated cells were treated 
for 72 h with control siRNA (scrambled, SC) or siRNA 
targeted against DGAT1 (SiD1) or DGAT2 (SiD2). 
mRNA determinations were performed on cells incu-
bated for 2 h either in the absence (-) or presence (+) 
of CL. The variances of input cDNA were normalized 
against the levels of three housekeeping genes: L19, 
B-actin, and 36B4, and expressed relative to those of 
SC, which were set at 1.0. Values are means (± SEM) 
for three separate experiments. Values that were sta-
tistically significantly different (P < 0.05) are indicated 
by * (vs. SC) and # (vs. SC+CL). ACC1, acetyl-CoA 
carboxylase 1; FASN, fatty acid synthase.
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adipocytes had very similar rates of glucose incorporation 
as IMBAT-1 cells (see above) but were more oxidative, sug-
gesting that the mobilization of the DGAT2-dependent 
TAG pool is even more rapid in primary cells.
Inhibition of DGAT2, but not DGAT1, prevents glucose conver-
sion into CO2. The CL-induced increase in CO2 produc-
tion from glucose was entirely prevented by inhibition of 
DGAT2 (Fig. 10A), confirming that, as in IMBAT-1 cells, 
the FA synthesized from glucose had to be incorporated 
into TAG before they could be oxidized (subsequent to li-
polysis). By contrast, inhibition of DGAT1 had no effect on 
the etomoxir-sensitive conversion of glucose into CO2. 
Therefore, the data obtained with primary brown adipo-
cytes fully confirmed the evidence for a specialized role of 
DGAT2 in channelling de novo synthesized FAs toward oxi-
dation in brown adipocytes. The effect of DGAT2 was mim-
icked by inhibition of CPT1 with etomoxir and by the 
inhibition of de novo lipogenesis by TOFA (Fig. 10A) con-
firming that DGAT2 action lies on a pathway linking DNL 
to FA oxidation in brown adipocytes.
lipolysis. De novo synthesized fatty acids appear to have been 
incorporated into a TAG pool in which a much higher spe-
cific activity of the acyl groups was achieved. Therefore, this 
pool must be considerably smaller and must turn over rapidly 
to give the linear and immediate CO2 formation observed.
These inferences were supported by the effects on exog-
enous 1-14C-oleate incorporation into TAG after the inhibi-
tion of either DGAT1 (using DGAT1-iB) or DGAT2 (using 
DGAT2-iJ). When added individually, each inhibitor af-
fected only marginally the incorporation of exogenous 
1-14C-oleate into TAG. However, incubation of cells simul-
taneously with both DGAT1-iB and DGAT2-iJ resulted in 
complete inhibition of labeling of TAG from exogenously 
added 1-14C-oleate (Fig. 9A). Therefore, the esterification 
of FAs derived from exogenous, preformed oleate (or pal-
mitate, not shown) can be catalyzed redundantly by either 
DGAT1 or DGAT2. Only the combined inhibition of the 
two enzymes significantly decreased esterification of exog-
enously added oleate into TAG (Fig. 9A). This was entirely 
different from the ability of DGAT2 downregulation spe-
cifically to inhibit TAG-acyl labeling from glucose.
Incorporation of 2-[3H]glycerol into TAG was maximally 
decreased by inhibition of DGAT1 (Fig. 9B). Although 
DGAT2 inhibition also moderately decreased 2-3H-glycerol 
incorporation into TAG, this effect was much smaller than 
that of DGAT1 inhibition, and combined DGAT2 and 
DGAT1 inhibition did not increase that achieved by DGAT1 
inhibition alone. Therefore, exogenous glycerol is used for 
the synthesis of DG, which serves preferentially as a sub-
strate for DGAT1 (Fig. 9B), whereas glucose-derived glyc-
erol-3-P is used preferentially for the synthesis of DG used 
by DGAT2 (Fig. 7E).
Experiments using mouse primary brown adipocytes
Having established the experimental conditions for the 
use of DGAT1 and DGAT2 inhibitors, we wanted to vali-
date the salient aspects of our observations using mouse 
primary brown adipocytes. This enabled us to ascertain 
that the same conclusions are applicable in a cell system 
closer to the physiological condition.
CL stimulates etomoxir-sensitive glucose incorporation into 
CO2. When primary brown adipocytes were treated with 
CL, the rate of CO2 formation from U-
14C-glucose was in-
creased by 5.5-fold (Fig. 10A). This was prevented by eto-
moxir, indicating that the glucose had to be converted into 
FA before it was oxidized. This inference was confirmed by 
the demonstration that incubation with 5-(tetradecyloxy)-
2-furoic acid (TOFA), an inhibitor of lipogenesis at the 
ATP-citrate lyase step, also inhibited the etomoxir-sensitive 
incorporation of glucose into CO2 to the same extent (Fig. 
10A). Although this scale of activation was similar to the 
4-fold stimulation by CL of etomoxir-sensitive conversion 
of glucose into CO2 observed in IMBAT-1 cells (see above), 
it occurred from a much lower background (control) of 
CO2 production in control primary cells. The absolute 
rates of incorporation of U-14C-glucose into CO2, TAG-acyl, 
and TAG-glyceryl were 15.1 ± 1.1, 10.0 ± 1.5, and 10.0 ± 2.1 
nmol/h/106 cells, respectively. Therefore, primary brown 
Fig. 9. Effects of individual or combined inhibition of DGAT1 
and DGAT2 on the incorporation of added oleate or glycerol into 
TAG. Cells were incubated with glucose, oleate, and glycerol (see 
text for concentrations). When present, CL was added 2 h before 
the addition of label, either (A) 1-14C-oleate or (B) 2-3H-glycerol. 
The inhibitors (DGAT1-iB to inhibit DGAT1 and DGAT2-iJ to in-
hibit DGAT2, specifically) were added 30 min before the addition of 
label. Values are means (± SEM) for three separate experiments. 
Values that are statistically significantly different from those for con-
trol (P < 0.05) are indicated by an asterisk.
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form a distinct pool of TAG. Inhibition of DGAT1 had no 
effect at all on incorporation of labeled glucose into 
TAG-acyl groups (as observed in IMBAT-1 cells). Al-
though there was a tendency for the inhibition of DGAT1 
to affect incorporation into TAG-glyceryl groups, the ef-
fect was less than that shown by DGAT2 inhibition (as in 
IMABT-1 cells), and did not reach statistical significance 
(Fig. 10 C).
Inhibition of DGAT2 but not of DAGT1 prevents incorpora-
tion of U-14C-glucose into TAG. Glucose incorporation 
into TAG-acyl and TAG-glyceryl moieties were both pre-
vented by DGAT2 inhibition in primary brown adipo-
cytes (Fig. 10 B, C). Moreover, this effect was mimicked 
by the inhibition of de novo FA synthesis with TOFA 
(an inhibitor of de novo lipogenesis) indicating that 
DGAT2 utilizes newly synthesized diglycerides and FA to 
Fig. 10. Effect of DGAT1 and DGAT2 inhibition on 
the incorporation of U-14C glucose into CO2 and TAG 
after 3-agonist stimulation of primary brown adipo-
cytes. Cells were incubated with CL for 2 h before the 
start of incubations by the addition of U-14C-glucose 
label. Inhibitors were added individually 30 min be-
fore the addition of label (see Methods section). Ex-
periments were performed in the presence of oleate 
(0.75 mM with 0.25% BSA) and glycerol (0.75 mM). 
Incorporation of label from U-14C-glucose was mea-
sured for a 2 h period into (A) CO2, (B) TAG-acyl, and 
(C) TAG-glyceryl moieties. The concentrations of in-
hibitors used were: DGAT1-iB, 0.75 µM; DGAT2-iC, 50 
µM, and DGAT2-iJ, 50 µM. Values are means (± SEM) 
for three separate experiments and are expressed with 
respect to values for controls (set at 100%) to which 
no CL or inhibitors were added. Values that were statis-
tical significantly different (P < 0.05) are indicated by 
* (CL vs. Control) and # (CL + inhibitors vs. CL only). 
See Methods section for details of statistical analysis. 
Etmox, etomoxir.
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(but not DGAT1) inhibition totally prevented incorpora-
tion of glucose into TAG-acyl and TAG-glyceryl moieties, 
and the formation of CO2 from de novo synthesized FAs. 
Indeed, because primary brown adipocytes are more oxida-
tive than IMBAT-1 cells, the role of DGAT2 in mediating 
the channelling of glucose carbons toward FA oxidation 
was even more pronounced. Moreover, we demonstrated 
that the effect of DGAT2 inhibition on these parameters 
could be mimicked by inhibition of de novo lipogenesis 
with TOFA, thus confirming the close link between DGAT2 
action and utilization of de novo synthesized FAs for TAG 
synthesis and subsequent oxidation.
The specialized role of DGAT2 in esterifying de novo 
synthesized FAs is similar to that described originally in 
HepG2 cells (1, 2). More recently, urokinase-type plasmin-
ogen activator has been shown to stimulate TAG synthesis 
from acetate, in parallel with increased DNL and the spe-
cific induction of the expression of DGAT2 (54). These 
observations suggest that this specialized function of 
DGAT2 may be a ubiquitous function of this enzyme in dif-
ferent cell types, with metabolic outcomes depending on 
tissue function; e.g., linking glycemia to triglyceridemia in 
the liver (2) and the channelling of glucose-derived FA to-
ward rapid oxidation in BAT (present data).
The ability of ATGL inhibition to prevent the CL-medi-
ated stimulation of CO2 formation from de novo synthe-
sized FA derived from glucose would be expected to result 
from the interruption of FA supply by inhibition of TAG 
lipolysis. However, in addition, ATGL inhibition also pre-
vented the stimulation of glucose incorporation into TAG 
(both glyceride and acyl moieties) indicating that a prod-
uct of lipolysis activates glucose metabolism by the cells 
through a positive feedback mechanism (Fig. 11). Inhibi-
tion of TAG lipolysis is suggested to have interrupted this 
feedback activation of one or more steps leading from glu-
cose to the synthesis of glycerol-3-P, de novo FA synthesis, 
and esterification into TAG. This is consistent with previous 
observations that in Atgl / mice, BAT shows diminished 
glucose uptake (55), and that ATGL expression is essential 
for 3-activation of DNL in BAT in vivo (37, 55). Our data 
suggest that DNL is specifically stimulated to a greater ex-
tent than incorporation of glucose-derived glyceryl moi-
eties into TAG; therefore, positive feedback activation of 
DNL may occur partly independently of the stimulation of 
triose-phosphate formation. The importance of ATGL in 
the provision of ligands for the positive feedback-activation 
of PPAR target gene activation is well established (56).
A proportion of the CO2 labeling from U-
14C-glucose 
arises during lipogenesis and the direct oxidation of the 
resulting acetyl-CoA through the TCA cycle; this is known 
to make only a minor contribution toward thermogenesis 
(19). We distinguished between this direct oxidation of 
glucose and the CO2 derived from FA oxidation by using 
etomoxir. This inhibitor of CPT1 decreased CO2 labeling 
only moderately in the absence of CL but totally pre-
vented the stimulation (4-fold in IMBAT-1 cells and 5.5-fold 
in primary adipocytes) mediated by CL, indicating that the 
increased formation of 14CO2 from glucose after CL stimu-
lation was entirely due to increased oxidation of de novo 
DISCUSSION
Glucose is one of the two major substrates used by BAT. 
The high rate of glucose uptake during cold exposure acts 
as a ‘glucose sink’, and has been suggested to be able to im-
prove insulin sensitivity physiologically during cold exposure 
(9, 45) and potentially to form the basis for pharmacologi-
cal strategies aimed at increasing glucose utilization by 
BAT to regulate blood glucose in obesity and diabetes (12, 
45, 46). However, BAT bioenergetics are centered around 
the uncoupled oxidation of FAs as the source of thermo-
genic capacity. Glucose-derived pyruvate makes only a mi-
nor direct contribution toward mitochondrial electron 
transport chain activity, although there is a strong relation-
ship between FA oxidation and glucose uptake in BAT 
(47). The simultaneous activation of glucose transport, de 
novo fatty acid synthesis and fatty acid oxidation in brown 
adipocytes by -adrenergic stimulation (14, 48, 49) is con-
sistent with the observations of increased expression of en-
zymes involved in FA synthesis (e.g., FSN), FA desaturation 
(SCD1) and FA elongation (e.g., Elvol3, Elvol6) after cold-
exposure or CL-treatment in vivo (13, 23, 37). However, the 
rationale for the oxidation of newly synthesized FAs has previ-
ously been questioned and considered paradoxical (9, 10). 
It has been proposed that the newly synthesized FAs are not 
oxidized immediately but are stored in lipid droplets in an-
ticipation of subsequent thermogenic activation (10, 24, 30).
The present study has addressed this apparent paradox 
by showing that, in brown adipocytes (primary cells and 
IMBAT-1 cell line), glucose-derived FAs are specifically 
channelled into a rapidly mobilized pool of TAG, which is 
distinct from the bulk TAG pool into which exogenous, 
preformed FAs are esterified. This is evidenced by the 
DGAT2-dependence of the labeling of CO2 derived from 
de novo synthesized FA, but not that derived from exoge-
nous oleate, in spite of equivalent overall labeling of total 
cellular TAG by either substrate. The ability of TOFA (an 
inhibitor of FA synthesis) to replicate the effects of DGAT2 
inhibition supports the concept that channelling of de 
novo synthesized FA toward oxidation occurs via DGAT2-
mediated TAG synthesis. This segregation of a glucose-
derived, DGAT2-dependent synthesis of a distinct pool of 
TAG enables the cell to oxidize de novo synthesized FA di-
rectly, and independently from preformed FA derived ex-
ogenously. Therefore, DGAT2 acts as the link between 
increased glucose utilization and uncoupled mitochon-
drial FA oxidation, as part of a concerted response of this 
pathway to adrenergic stimulation in brown adipocytes 
(see Fig. 11). Previous observations in vivo had found evi-
dence for distinct pools of TAG being used to channel FAs 
toward oxidation or esterification (50, 51) and for the dif-
ference of the stereospecific distribution of de novo synthe-
sized and exogenous FAs in cellular TAG (52, 53). The 
current observations on the specialized role of DGAT2 in 
brown adipocytes provide a mechanism through which 
these distinct TAG pools could be achieved, if the concept 
can be extended to other cell types.
When we tested this concept in primary brown adipo-
cytes, we found that, in this cellular model too, DGAT2 
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DGAT2-dependent manner. GPAT4 expression was at least 
partly dependent on continued DGAT2 expression in IM-
BAT-1 cells (Fig. 8B), and may play a major role in ensuring 
that both endogenously derived and exogenously added 
FAs are esterified to TAG prior to oxidation.
In IMBAT-1 cells, DGAT1 and DGAT2 act redundantly 
for the incorporation of glucose-derived glycerol-3-P into 
TAG, although less so after longer-term knockdown. How-
ever, exogenous glycerol is used preferentially for the for-
mation of DG utilized by DGAT1, indicating that the two 
enzymes also have differential access to DG synthesized 
from exogenous or endogenously synthesized glycerol-3-P. 
This compartmentalization is different from the observa-
tions previously made on two liver systems [HepG2 cells (1) 
and murine liver (5)] in which DGAT2 is specialized for the 
incorporation of exogenous glycerol into TAG. This differ-
ence in the handling of glycerol-3-P formed from exoge-
nous glycerol may reflect the differences between the 
metabolism of TAG in liver and BAT. Thus, lipolysis in BAT 
goes to completion (to glycerol and FA) whereas it is mostly 
restricted to the formation of DG and monoglyceride in the 
liver; e.g., in rat liver in vivo (62 ,63) and in primary rat he-
patocytes (64). Therefore, in BAT, the lipolysis-reesterifica-
tion cycling occurs between TAG and FA whereas in the 
liver, cycling occurs primarily between DG and TAG, or 
monoglyceride and DG (64) without the release of glyc-
erol. In the liver, DG is mostly used for the resynthesis of 
TAG either for maintenance of cytosolic TAG stores in lipid 
droplets or incorporated into VLDL (1, 2, 65). The special-
ization of specific enzyme isoforms for the channelling of 
FA is increasingly being recognized [see (61, 66)].
In summary, all our data on primary brown adipocytes 
and a brown adipocyte-derived cell line indicate that the 
DGAT2-dependent pool of TAG is distinct from that into 
which exogenous, preformed FAs are esterified. As a result, 
newly synthesized FAs are made immediately available for 
mitochondrial oxidation in a DGAT2-dependent manner. 
synthesized FAs. Importantly, the CL-mediated and eto-
moxir-sensitive stimulation of CO2 labeling from glucose 
was specifically prevented by downregulation of DGAT2 
but not of DGAT1. This indicated that i) DNL and TAG 
synthesis precede the formation of CO2, and ii) that 
DGAT2 is specifically involved in this pathway. Such sensi-
tivity to DGAT2 downregulation reinforces the conclusion 
that CO2 production does not occur directly from the de 
novo synthesized FAs but only subsequent to TAG forma-
tion. Oxidation of exogenously added fatty acids is de-
duced to have been similarly indirect in IMBAT-1 cells 
because detection of labeled CO2 or ASM formation was 
very low when cells were incubated with 1-14C-oleate or 
U-14C-palmitate, in spite of their very rapid labeling of cel-
lular TAG. This was also the case in primary cells (not 
shown). This can be explained if the added 14C-oleate was 
esterified into a large, preexisting pool of TAG within 
which its specific activity was highly diluted. This indirect 
route for FA oxidation has been described for several tis-
sues and cell types (57–60).
It is well-established that the activation of ATGL by 3-
adrenergic agonism promotes TAG turnover by simultane-
ously promoting glucose uptake and DNL, including the 
induction of proteins involved in DNL (37), thus providing 
substrates for DGAT2. Because of the importance of long-
chain acyl-CoA synthase 1 (ACSL1) in channelling FA 
(whether supplied exogenously or synthesized de novo) to-
ward mitochondrial -oxidation and of GPAT4 in diverting 
FA toward TAG synthesis (27, 61), we considered whether 
the very low rates of labeling of 14CO2 from exogenously 
added 1-14C-oleate to generate directly could have been due 
to a low expression of ACSL1 from IMBAT-1 cells. This pos-
sibility was excluded because we detected high levels of ex-
pression of ACSL1 mRNA (Fig. 8). In addition, adequate 
expression of ACSL1 can also be inferred from the observa-
tion that de novo synthesized FAs were oxidized rapidly to 
CO2 simultaneously with TAG labeling from glucose in a 
Fig. 11. Proposed pathways that link DGAT2 to de novo fatty acid synthesis and thermogenesis in brown adi-
pocytes. Fatty acids synthesized de novo from glucose (FA’’) are used to form a pool of diglyceride (DG’’) which 
is esterified with FA’’ by DGAT2 to form a distinct pool of triglyceride (TG’’). Adrenergic (3) stimulation si-
multaneously activates de novo lipogenesis and TAG lipolysis. A product of lipolysis activates the process of 
glucose utilization for lipogenesis (DNL) upon stimulation of the cells by 3-agonists through a positive feed-
back mechanism which is interrupted by inhibition of ATGL. TAG lipolysis provides FA substrate for uncoupled 
mitochondrial oxidation. FA activate UCP1, the expression of which is increased by 3-action. Glycerol-3-P 
synthesized from exogenous glycerol is used for the synthesis of a separate DG pool (DG’) which is used as a 
substrate for re/esterification preferentially by DGAT1, and to a lesser extent by DGAT2. Glycerol-3-P gener-
ated endogenously from glucose is used to form both DG’’ and DG’. Exogenous FA is not oxidized directly, but 
is re/esterified by DGAT1 or DGAT2 redundantly into/within a larger TAG pool (TAG’) before oxidation. 
 by guest, on August 8, 2019
w
w
w
.jlr.org
D
ow
nloaded from
 
.html 
http://www.jlr.org/content/suppl/2016/11/11/jlr.M068197.DC1
Supplemental Material can be found at:
DGAT2 enables BAT thermogenesis from glucose 29
hormone-sensitive lipase, and diacylglycerol-O-acyltransferases. J. Biol. 
Chem. 287: 41446–41457.
 5. Qi, J., W. Lang, J. G. Geisler, P. Wang, I. Petrounia, S. Mai, C. Smith, 
H. Askari, G. T. Struble, R. Williams, et al. 2012. The use of stable 
isotope-labeled glycerol and oleic acid to differentiate the hepatic 
functions of DGAT1 and -2. J. Lipid Res. 53: 1106–1116.
 6. Chen, H. C., S. J. Smith, Z. Ladha, D. R. Jensen, L. D. Ferreira, 
L. K. Pulawa, J. G. McGuire, R. E. Pitas, R. H. Eckel, and R. V. Farese. 
2002. Increased insulin and leptin sensitivity in mice lacking acyl 
CoA:diacylglycerol acyltransferase 1. J. Clin. Invest. 109: 1049–1055.
 7. Stone, S., H. M. Myers, S. M. Watkins, B. E. Brown, K. R. Feingold, 
P. M. Elias, and R. V. Farese. 2004. Lipopenia and skin barrier abnor-
malities in DGAT2-deficient mice. J. Biol. Chem. 279: 11767–11776.
 8. Li, C., L. Li, J. Lian, R. Watts, R. Nelson, B. Goodwin, and R. Lehner. 
2015. Roles of acyl-CoA:diacylglycerol acyltransferases 1 and 2 in 
triacylglycerol dynthesis and decretion in primary hepatocytes. 
Arterioscler. Thromb. Vasc. Biol. 35: 1080–1091.
 9. Townsend, K. L., and Y. H. Tseng. 2014. Brown fat fuel utilization 
and thermogenesis. Trends Endocrinol. Metab. 25: 168–177.
 10. Cannon, B., and J. Nedergaard. 2004. Brown adipose tissue: func-
tion and physiological significance. Physiol. Rev. 84: 277–359.
 11. Villarroya, F., and A. Vidal-Puig. 2013. Beyond the sympathetic tone: 
the new brown fat activators. Cell Metab. 17: 638–643.
 12. Whittle, A. J., M. Lopez, and A. Vidal-Puig. 2011. Using brown adipose 
tissue to treat obesity - the central issue. Trends Mol. Med. 17: 405–411.
 13. Hankir, M. K., M. A. Cowley, and W. K. Fenske. 2016. A BAT-centric 
approach to the treatment of diabetes: turn on the brain. Cell Metab. 
24: 31–40.
 14. Trayhurn, P. 1981. Fatty acid synthesis in mouse brown adipose tis-
sue. The influence of environmental temperature on the propor-
tion of whole-body fatty acid synthesis in brown adipose tissue and 
the liver. Biochim. Biophys. Acta. 664: 549–560.
 15. Olsen, J. M., M. Sato, O. S. Dallner, A. L. Sandstrom, D. F. Pisani, 
J. C. Chambard, E. Z. Amri, D. S. Hutchinson, and T. Bengtsson. 2014. 
Glucose uptake in brown fat cells is dependent on mTOR complex 
2-promoted GLUT1 translocation. J. Cell Biol. 207: 365–374.
 16. Albert, V., K. Svensson, M. Shimobayashi, M. Colombi, S. Munoz, V. 
Jimenez, C. Handschin, F. Bosch, and M. N. Hall. 2016. mTORC2 
sustains thermogenesis via Akt-induced glucose uptake and glycoly-
sis in brown adipose tissue. EMBO Mol. Med. 8: 232–246.
 17. Saggerson, E. D., T. W. McAllister, and H. S. Baht. 1988. Lipogenesis 
in rat brown adipocytes. Effects of insulin and noradrenaline, con-
tributions from glucose and lactate as precursors and comparisons 
with white adipocytes. Biochem. J. 251: 701–709.
 18. Ma, S. W., and D. O. Foster. 1986. Uptake of glucose and release of 
fatty acids and glycerol by rat brown adipose tissue in vivo. Can. J. 
Physiol. Pharmacol. 64: 609–614.
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I. C. Kettelhut, and R. Migliorini. 1999. Brown adipose tissue triac-
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free diet. Am. J. Physiol. 276: R1003–R1009.
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of glycolysis in brown adipose tissue and its relationship to control 
of the blood glucose concentration. FEBS Lett. 148: 198–200.
 21. Minokoshi, Y., M. Saito, and T. Shimazu. 1988. Sympathetic activa-
tion of lipid synthesis in brown adipose tissue in the rat. J. Physiol. 
398: 361–370.
 22. Yu, X. X., D. A. Lewin, W. Forrest, and S. Adams. 2002. Cold elicits 
the simultaneous induction of fatty acid synthesis and beta-oxidation 
in murine brown adipose tissue: prediction from differential gene 
expression and confirmation in vivo. FASEB J. 16: 155–168.
 23. Tan, C Y., S. Virtue, G. Bidault, M. Dale, R. Hagen, J. L. Griffin, and 
A. Vidal-Puig. 2015. Brown adipose tissue thermogenic capacity is 
regulated by Elovl6. Cell Reports. 13: 2039–2047.
 24. Festuccia, W. T., P. G. Blanchard, V. Turcotte, M. Laplante, 
M. Sariahmetoglu, D. N. Brindley, D. Richard, and Y. Deshaies. 
2009. The PPARgamma agonist rosiglitazone enhances rat brown 
adipose tissue lipogenesis from glucose without altering glucose up-
take. Am. J. Physiol. Regul. Integr. Comp. Physiol. 296: R1327–R1335.
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T. Viljanen, M. Scheinin, M. Taittonen, T. Niemi, S. Enerback, et al. 
2011. Different metabolic responses of human brown adipose tissue 
to activation by cold and insulin. Cell Metab. 14: 272–279.
 26. Isler, D., H. P. Hill, and M. Meier. 1987. Glucose metabolism in 
isolated brown adipocytes under beta-adrenergic stimulation. 
Quantitative contribution of glucose to total thermogenesis. Biochem. 
J. 245: 789–793.
By contrast, exogenous FAs are esterified into a separate, 
larger, preexisting pool of TAG. Assuming that this pool of 
TAG is itself mobilized during -adrenergic stimulation, 
this indicates that exogenous FAs and de novo synthesized 
FAs are esterified into separate TAG pools before being oxi-
dized. However, whereas DGAT2 is exclusively responsible 
for the formation of the TAG pool specific for de novo syn-
thesized FAs, it also participates, together with DGAT1, in 
the (re)esterification of exogenous FAs into the larger pool 
of cellular TAG. These data suggest that within the multi-
locular structure of BAT lipid droplets, a sub-population of 
droplets originate specifically as a result of DGAT2 activity, 
enriched in de novo synthesized FAs and preferentially mo-
bilized to enable glucose to contribute immediately toward 
thermogenesis. This is consistent with the previous observa-
tion that within a given cell, individual lipid droplets have 
differential access to the TAG biosynthetic machinery (67).
The very high level of expression of DGAT2 mRNA in 
the tissue in vivo and its large fold-induction and persis-
tence during IMBAT-1 cell differentiation are indicative of 
the importance of DGAT2 expression for BAT function. In 
this context, the 4-fold induction of UCP1 in IMBAT-1 cells 
upon CL-stimulation is markedly blunted after knockdown 
of DGAT2 expression, suggesting that DGAT2 expression 
is important for the maintenance of the brown adipocyte 
phenotype. It is noteworthy that Dgat2/ mice do not sur-
vive beyond 12 h after birth. This has been ascribed to de-
fects in skin lipid synthesis and the associated dehydration 
(7). Our data raise the possibility that they may also be un-
able to thermoregulate normally. It is well established that 
deficient thermogenesis results in increased mortality in 
neonatal rodents (68) and that prevention of glucose up-
take by BAT in vivo by downregulation of mTORC2 results 
in hypothermia (16). Although it is likely that the contribu-
tion that glucose makes toward heat production in BAT is 
not fully developed in the neonate [owing to the lower 
rates of DNL in the tissue before weaning (14)] it would 
become more important as the pups switch to a high carbo-
hydrate diet upon weaning (at 3 weeks of age) such that 
glucose- and DGAT2-dependent nonshivering thermogen-
esis might become critical for survival postweaning.
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